Source: Canadian Agency for Drugs and Technologies in Health (CADTH)
Area: News
This Canadian review examined the clinical effectiveness, safety and economic literature on fusidic acid to help inform a funding decision.
The evidence on the clinical effectiveness and safety of fusidic acid for eye infections was limited to three lower quality RCTs which noted the following:
. Short term (7 day) treatment with topical fusidic acid resolved clinical signs and symptoms of conjunctivitis or chronic blepharitis in 76% to 91% of patients compared to 73% to 93% of (Read more...)
Uncategorized